Zacks Investment Research on MSN
BHC's late-stage liver cirrhosis studies fail, stock down
Shares of Bausch Health BHC were down 1.86% on Jan. 26. This was the second consecutive session when shares slid. BHC stock ...
Bausch Health, along with its gastroenterology business, Salix Pharmaceuticals, has filed a lawsuit in the United States District Court for the District of New Jersey against Amneal Pharmaceuticals of ...
Bausch Health BHC, along with its gastroenterology business, Salix Pharmaceuticals, Inc., announced that it has filed a lawsuit against Amneal Pharmaceuticals AMRX and its subsidiaries. The lawsuit ...
LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. (BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today acknowledged that the Centers for Medicare and ...
Shares of Bausch Health Companies, Inc. BHC gained 5.3% after it obtained a favorable ruling from the U.S. District Court of Delaware for one of its top drugs, Xifaxan (rifaximin). Xifaxan 550 mg ...
Bausch Health, and its gastroenterology business Salix Pharmaceuticals announced that the U.S. District Court for the District of Columbia in the matter of Norwich Pharmaceuticals v. Becerra, et al.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results